{"title": "The Rockefeller University - COVID-19 research", "author": null, "url": "https://covid-19-research.rockefeller.edu/", "hostname": "rockefeller.edu", "description": null, "sitename": "The Rockefeller University - COVID-19 research", "date": "2020-01-16", "cleaned_text": "Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19 February 3, 2021 The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant "}